COVID-19 and transport safety

被引:5
|
作者
Marshall, Ennis [1 ]
Shirazi, Mohammadali [1 ,3 ]
Ivan, John N. [2 ]
机构
[1] Univ Maine, Dept Civil & Environm Engn, Orono, ME USA
[2] Univ Connecticut, Dept Civil & Environm Engn, Storrs, CT USA
[3] Univ Maine, Dept Civil & Environm Engn, Orono, ME 04469 USA
关键词
COVID-19; roadway safety; transit safety; ped/bike safety; speeding; aggressive driving; SPEED; BEHAVIOR; IMPACT; ROADS; RISK;
D O I
10.1080/01441647.2023.2251684
中图分类号
U [交通运输];
学科分类号
08 ; 0823 ;
摘要
Transportation safety has substantially been impacted by the COVID-19 Pandemic. To contain the spread of the virus, governments around the world released guidelines (e.g. stay-at-home orders), which reduced or eliminated peoples' daily commutes. These travel restrictions introduced new safety challenges for roadways and drivers, transit riders, and pedestrians and cyclists. Many cities, states, and countries around the world reported more severe crashes despite fewer drivers on the road. Transit ridership reduced as the risk of infection with COVID-19 kept transit users away, and walking and biking became more popular as they could be done individually in open air. This paper conducts a structured critical review to summarise and discuss studies around the world on roadway, transit, and pedestrian and bicycle safety since the start of the COVID-19 pandemic. For roadway safety, we further review studies that examine the direct measures of safety (e.g. crash statistics and models) as well as indirect or surrogate measures (e.g. speeding, aggressive driving, and reduced seatbelt usage). Surrogate measures, although indirectly, can affect the risk of crashes and contribute to the increase in frequency and severity of crashes. Findings are documented and discussed. We then provide suggestions on potential avenues for future research. Particularly, research studies show that the rate of severe injury crashes, as well as aggressive driving (e.g. speeding) increased in most places during the travel restrictions, and continued even after these restrictions were lifted. The safety of pedestrians and bicycles has also become increasingly important due to the increase in the number of users of these modes.
引用
收藏
页码:518 / 543
页数:26
相关论文
共 50 条
  • [1] Safety of COVID-19 vaccines
    Aga, Qutaiba A. Al Khames
    Alkhaffaf, Waseem H.
    Hatem, Tagreed H.
    Nassir, Kawthar F.
    Batineh, Yazan
    Dahham, Abdullah T.
    Shaban, Dimah
    Aga, Luma A. Al Khames
    Agha, Manhal Y. R.
    Traqchi, Muaamar
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (12) : 6588 - 6594
  • [2] Safety of COVID-19 vaccines
    Virginia, Rasi
    Guido, Rasi
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 112 : 15 - 16
  • [3] COVID-19 vaccine safety
    Amaro Hosey, Kristopher
    Quijada Manuitt, Maria Angeles
    Antoniajoan Arbos, Rosa
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 32 - 32
  • [4] COVID-19 vaccine safety
    Kostoff, Ronald N.
    Briggs, Michael B.
    Porter, Alan L.
    Spandidos, Demetrios A.
    Tsatsakis, Aristidis
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 46 (05) : 1599 - 1602
  • [5] Covid-19, transport and mobility
    Bouzouina, Louafi
    Kourtit, Karima
    Nijkamp, Peter
    REGIONAL SCIENCE POLICY AND PRACTICE, 2022, 14 : 3 - 5
  • [6] Statins and COVID-19: emerging evidence on the safety and efficacy of statins in COVID-19
    Kapur, Shweta
    Lohia, Prateek
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (04) : 1157 - 1159
  • [7] ChatGPT and safety of COVID-19 vaccines
    Daungsupawong, Hinpetch
    Wiwanitkit, Viroj
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [8] COVID-19 and the US Safety Net*
    Moffitt, Robert A.
    Ziliak, James P.
    FISCAL STUDIES, 2020, 41 (03) : 515 - 548
  • [9] Road safety and the COVID-19 pandemic
    Mendez, Gomez
    Carreteras, 2020, 4 (231): : 88 - 89
  • [10] Safety of Tocilizumab in Patients with Covid-19
    Gundling, S.
    Popa, A.
    Tumbush, C.
    Hejal, R. B.
    Giddings, O. K.
    Teba, C.
    John, A. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)